One year randomized controlled trial to compare the effectiveness of honey dressing versus povidone iodine dressing for diabetic foot ulcer at Dr. Prabhakar Kore Hospital and MRC, Belagavi
Keywords:Unprocessed honey dressing, Diabetic foot ulcers, Povidone iodine dressing
Background: The objective of the study is to find out the effect of honey dressing versus povidone iodine dressing for reduction of wound size in diabetic foot ulcer.
Methods: This randomized controlled trial was done in the Department of General Surgery, KLES Dr. Prabhakar Kore Hospital, Belagavi from January 2017 to December 2017. 64 patients were randomized into 32 group each undergoing unprocessed honey dressing and other group undergoing povidone iodine dressing.
Results: The mean wound size in honey dressing was 23.16 cm2 and 23.03 cm2 in povidone dressings at baseline, 23.16 cm2 and 22.94 cm2 at 1st day follow up, 23.16 cm2 and 22.94 cm2 at 3rd day follow up, 19.38 cm2 and 20.28 cm2 at 5th day follow up, 16.13 cm2 and 17.06 cm2 at 7th day follow up, 12.44 cm2 and 16.13 cm2 at 10th day follow up and the end of 15th day, it was 10.69 cm2 and 15.06 cm2 respectively in honey dressing group and povidone dressing group. The difference in the wound size in honey dressing group and povidone dressing group at 1st day, 3rd day, 5th day, 7th day, 10th day follow up period were statistically not significant (p>0.05). The difference in the wound size in honey dressing group at 15th day follow up period were statistically significant (p<0.05).
Conclusions: This study shows more favorable results with honey dressing for reduction of wound size in diabetic foot ulcers.
Bahrami M, Ataie-Jafari A, Hosseini S, Foruzanfar MH, Rahmani M, Pajouhi M. Effects of natural honey consumption in diabetic patients: an 8-week randomized clinical trial. Intl J Food Sci Nutr. 2009;60(7):618-26.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(4):1047-53.
Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metabol Clin North Am. 2010;39(3):481-97.
Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care. 2009;32(2):287-94.
Gregg EW, Cadwell BL, Cheng YJ, Cowie CC, Williams DE, Geiss L, et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes Care. 2004;27(12):2806-12.
Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia. The Lancet. 2006;368(9548):1681-8.
World Diabetes Media Kit: every 10 seconds 1 person dies of diabetes. Brussels, Belgium: International Diabetes Federation; 2007.
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. J Am Med Assoc. 2005;293(2):217-28.
Lavery LA, Higgins KR, Lanctot DR, Constantinides GP, Zamorano RG, Athanasiou KA, et al. Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a self-assessment tool. Diabetes Care. 2007;30(1):14-20.
Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990;13(5):513-21.
Larsson J, Agardh CD, Apelqvist J, Stenström A. Long term prognosis after healed amputation in patients with diabetes. Clin Orthop Related Res. 1998;350:149-58.
Aljadi AM, Yusoff KM. Isolation and identification of phenolic acids in Malaysian honey with antibacterial properties. Turk J Med Sci. 2003;33(4):229-36.
Khanolkar MP, Bain SC, Stephens JW. The diabetic foot. QJM. 2008;101(9):685-95.
Frykberg RG, Veves A. Diabetic foot infections. Diabetes/Metabol Review. 1996;12(3):255-70.
Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes Diabetes Care. 2003;26(1):S78-9.
American Diabetes Association. Consensus development conference on diabetic foot wound care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association. Diabetes Care. 1999;22(8):1354-60.
Armstrong DG, Lipsky BA. Diabetic foot infections: stepwise medical and surgical management. Intl Wound J. 2004;1(2):123-32.
Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29(6):1288-93.
Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004;39(7):885-910.
Zgonis T, Stapleton JJ, Girard-Powell VA, Hagino RT. Surgical management of diabetic foot infections and amputations. AORN J. 2008;87(5):935-50.
Tentolouris N, Al-Sabbagh S, Walker MG, Boulton AJM, Jude EB. Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year followup study. Diabetes Care. 2004;27(7):1598-604.
Schofield CJ, Libby G, Brennan GM, Macalpine RR, Morris AD, Leese GP. Mortality and hospitalization in patients after amputation: a comparison between patients with and without diabetes. Diabetes Care. 2006;29(10):2252-6.
Boutoille D, F´eraille A, Maulaz D, Krempf M. Quality of life with diabetes-associated foot complications: comparison between lower-limb amputation and chronic foot ulceration. Foot Ankle Intl. 2008;29(11):1074-8.
Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg. 1998;176(2):5-10.
Robbins JM, Strauss G, Aron D, Long J, Kuba J, Kaplan Y. Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration?. J Am Podiatr Med Assoc. 2008;98(6):489-93.
Nguyen D, Orgill D, Murphy G. The Pathophysiologic Basis for Wound Healing and Cutaneous Regeneration. Elsevier; 2009.
Majtan J. Methylglyoxal- a potential risk factor of manuka honey in healing of diabetic ulcers. Evidence-based Complement Alternative Med. 2011;2011:295494.
Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemotherap. 2001;47(5):589-98.
Appelgren P, Björnhagen V, Bragderyd K, Jonsson CE, Ransjö U. A prospective study of infections in burn patients. Burns. 2002;28(1):39-46.
Abd-El Aal A, El-Hadidy M, El-Mashad N, El-Sebaie A. Antimicrobial effect of bee honey in comparison to antibiotics on organisms isolated from infected burns. Annals Burns Fire Disaster. 2007;20(2):83-8.
Saraf R, Bowry V, Rao D, Saraf P, Molan P. The antimicrobial efficacy of Fijian honeys against clinical isolates from diabetic foot ulcers. J API Product API Med Sci. 2009;1(3):64-71.
Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nature Reviews Drug Discovery. 2007;6(1):29-40.
El-Soud NHA. Honey between traditional uses and recent medicine. Macedon J Med Sci. 2012;5(2):205-14.
Stephen-Haynes J, Gibson E, Greenwood M. Chitosan: a natural solution for wound healing. J Community Nurs. 2014;28(1):48-53.
Gethin G, Cowman S. Manuka honey vs. hydrogel- a prospective, open label, multicentre, randomised controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers. J Clin Nurs. 2009;18(3):466-74.
Jull A, Walker N, Parag V, Molan P, Rodgers A. Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. Br J Surg. 2008;95(2):175-82.
Sheckter C, van Vliet MM, Krishnan NM, Garner WL. Cost effectiveness comparison between topical silver sulfadiazine and enclosed silver dressing for partial-thickness burn treatment. J Burn Care Res. 2014;35(4):284-90.
Boekema BKHL, Pool L, Ulrich MMW. The effect of a honey based gel and silver sulphadiazine on bacterial infections of in vitro burn wounds. Burns. 2013;39(4):754-9.
Oluwatosin OM, Olabanji JK, Oluwatosin OA, Tijani LA, Onyechi HU. A comparison of topical honey and phenytoin in the treatment of chronic leg ulcers. Afr J Med Med Sci. 2000;29(1):31-4.
Biglari B, Linden PH, Simon A, Aytac S, Gerner HJ, Moghaddam A. Use of Medihoney as a non-surgical therapy for chronic pressure ulcers in patients with spinal cord injury. Spinal Cord. 2012;50(2):165-9.
Güneş UY, Eşer I. Effectiveness of a honey dressing for healing pressure ulcers. J Wound, Ostomy Continence Nurs. 2007;34(2):184-90.
Johnson DW, van Eps C, Mudge DW, Wiggins KJ, Armstrong K, Hawley CM, et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney)versus mupirocin for the prevention of catheter associated infections in hemodialysis patients. J Am Societ Nephrol. 2005;16(5):1456-62.
Bang LM, Buntting C, Molan P. The effect of dilution on the rate of hydrogen peroxide production in honey and its implications for wound healing. J Alternative Complementary Med. 2003;9(2):267-73.
Subrahmanyam M, Sahapure A, Nagane N, Bhagwat V, Ganu J. Effects of topical application of honey on burn wound healing. Annals Burns Fire Disaster. 2001;14:143-5.
White R, Molan P. A summary of published clinical research on honey in wound management. Wounds. 2005:130-42.
Molan PC. The evidence supporting the use of honey as a wound dressing. Intl J Lower Extremity Wound. 2006;5(1):40-54.
Ahmed AKJ, Hoekstra MJ, Hage JJ, Karim RB. Honey-medicated dressing: transformation of an ancient remedy into modern therapy. Annals Plastic Surg. 2003;50(2):143-8.
Maeda Y, Loughrey A, Earle JA, Millar BC, Rao JR, Kearns A, et al. Antibacterial activity of honey against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Complement Therap Clin Practice. 2008;14(2):77-82.
White JW, Subers MH, Schepartz AI. The identification of inhibine, the antibacterial factor in honey, as hydrogen peroxide and its origin in a honey glucose-oxidase system. Biochimica et Biophysica Acta. 1963;73(1):57-70.
Gulati S, Qureshi A, Srivastava A, Kataria K, Kumar P, Balakrishna A. A prospective randomized study to compare the effectiveness of honey dressing vs. povidone iodine dressing in chronic wound. Healing Indian J Surg. 2014;76(3):193-8.